Cefaclor
규격
53994-73-3CAS 번호
258-909-5EC 번호
(6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acidIUPAC 명칭
C15H14ClN3O4S화학식
367.8 g/mol분자량
cefaclor; 53994-73-3; Cephaclor; Ceclor; Cefaclor anhydrous; Cefaclorum; Raniclor; Ceclor CD; Cefaclor hydrate; DTXSID3022748; 3-Chloro-7-D-(2-phenylglycinamido)-3-cephem-4-carboxylic acid; 3Z6FS3IK0K; Lilly 99638; S 6472; CHEBI:3478; (6R,7R)-7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; DTXCID002748; (6R,7R)-7-[(2R)-2-amino-2-phenylacetamido]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; NSC-757422; (6R,7R)-7-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-(((2R)-2-AMINO-2-PHENYLACETYL)AMINO)-3-CHLORO-8-OXO-5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, (6R-(6-alpha,7-beta(R*)))-; Keftid; Bacticlor mr; Distaclor mr; (6R,7R)-7-((2R)-2-amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((aminophenylacetyl)amino)-3-chloro-8-oxo-, monohydrate, (6R-(6alpha,7beta(R*)))-; RefChem:124193; (6R,7R)-7-((2R)-2-Amino-2-phenylacetylamino)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; 258-909-5; 69K7K19H4L; COMPOUND 99638; COMPOUND-99638; Distaclor; J01DC04; S6472; Kefral; Panoral; Cefaclor [INN]; Cefaclorum [INN-Latin]; MFCD00151471; Cefaclor Impurity C; CCL; 143059-69-2; MLS000069617; (6R,7R)-7-((R)-2-amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid,7-[[(2R)-aminophenylacetyl]amino]-3-chloro-8-oxo-, (6R,7R)-; NCGC00022612-04; Alfacet; SMR000058250; L-Kefral; Dystaclor MR; Alenfral (TN); (6R,7R)-7-((R)-2-Amino-2-phenylacetamido)-3-chloro-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2R)-2-amino-2-phenyl-acetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7-((2R)-2-amino-2-phenylacetylamino)(7R,7aR)-3-chloro-6-oxo-2H,7H-azetidino[2, 1-b]1,3-thiazine-4-carboxylic acid; CAS-53994-73-3; UNII-3Z6FS3IK0K; CefaclorImpurityC; Cefaclor CRS; S-6472; 5-THIA-1-AZABICYCLO(4.2.0)OCT-2-ENE-2-CARBOXYLIC ACID, 7-(((2R)-2-AMINO-2-PHENYLACETYL)AMINO)-3-CHLORO-8-OXO-, (6R,7R)-; 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2R)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-, (6R,7R)-; EINECS 258-909-5; 53994-73-3 (free); Cefaclor (Standard); Cefaclor (JP18); Spectrum_001070; SpecPlus_000947; CEFACLOR [JAN]; CEFACLOR [MI]; Prestwick0_000485; Prestwick0_001102; Prestwick1_000485; Prestwick1_001102; Prestwick2_000485; Prestwick2_001102; Prestwick3_000485; Prestwick3_001102; Spectrum2_001189; Spectrum3_001858; Spectrum4_000093; Spectrum5_001727; CEFACLOR [WHO-DD]; CHEMBL680; Epitope ID:117133; SCHEMBL33540; BSPBio_000349; BSPBio_001204; BSPBio_003276; KBioGR_000386; KBioSS_001550; cid_51039; MLS001424193; DivK1c_007043; SPECTRUM1500771; SPBio_001237; SPBio_002270; SPBio_003082; BPBio1_000385; BPBio1_001326; orb1685687; BDBM42131; HY-B0198R; KBio1_001987; KBio2_001550; KBio2_004118; KBio2_006686; KBio3_002777; HMS1571M06; HMS1921G22; HMS2052C11; HMS2092K08; HMS2233M13; Pharmakon1600-01500771; HY-B0198; MSK10007; Tox21_110880; CCG-40264; EBC-26813; NSC757422; AKOS024282614; Tox21_110880_1; AC34967; Cefaclor, analytical reference material; DB00833; NC00354; 7beta-{[(2R)-2-amino-2-phenylacetyl]amino}-3-chloro-3,4-didehydrocepham-4-carboxylic acid; NCGC00015260-22; NCGC00022612-05; NCGC00022612-06; NCGC00022612-07; NCGC00022612-10; NCGC00022612-11; AS-74992; CEFACLOR IMPURITY C [EP IMPURITY]; ST057228; SY247820; SBI-0051606.P002; AB00052174; C3478; NS00000499; T6436; A12614; C06877; D00256; AB00052174_15; AB00052174_16; EN300-19651305; F463447; Q415167; SR-05000001556; SR-05000001556-1; BRD-K20338176-001-16-9; BRD-K20338176-001-17-7; BRD-K20338176-001-18-5; BRD-K20338176-002-03-5; 7-(D-2-AMINO-2-PHENYLACETAMIDO)-3-CHLORO-3-CEPHEM-4-CARBOXYLIC; (6R,7R)-7-[(R)-2-AMINO-2-PHENYLACETAMIDO]-3-CHLORO-8-OXO-5-THIA-1-AZABICYCLO[4,2,0]OCT-2-ENE-2-CARBOXYLIC ACID; (6R,7R)-7-[[(2R)-2-azaniumyl-2-phenylacetyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate; (6R,7R)-7-[[(2S)-2-amino-1-oxo-2-phenylethyl]amino]-3-chloro-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Cefaclor monohydrate; Cefaclor monohydrat동의어
Cefaclor 함유 제품
세클원서방정375밀리그램(세파클러수화물)세파모아캡슐(세파클러수화물) 세파쿨러캡슐(세파클러수화물)세파로딘캡슐(세파클러수화물)세나클러캡슐(세파클러수화물)세파클리어캡슐(세파클러수화물)세파킴캡슐(세파클러수화물)세클리캡슐(세파클러수화물)제이세파캡슐250밀리그램(세파클러수화물)세파쿨캡슐(세파클러수화물)세파크린캡슐(세파클러수화물)세파시드캡슐(세파클러수화물)
1/35 페이지
Cefaclor 판매 기업
한미
한미약품(주)Republic of Korea(주
(주)동구바이오제약Republic of Korea(주
(주)휴온스Republic of Korea동국
동국제약(주)Republic of Korea(주
(주)유한양행Republic of Korea한림
한림제약(주)Republic of Korea(주
(주)한풍제약Republic of Korea(주
(주)테라젠이텍스Republic of Korea삼진
삼진제약(주)Republic of Korea(주
(주)보령Republic of Korea1/20 페이지